| PI3K | Phosphatidylinositol3-kinase |
| AKT | Protein kinase B |
| mTOR | Mechanistic target of rapamycin |
| MAPK | Mitogen-activated protein kinase |
| ERK | Extracellular-regulated protein kinases |
| JNK | C-Jun N-terminal kinase |
| NFκB | Nuclear factor kappa-B |
| SBP | Scutellaria barbata polysaccharide |
| GC-MS | Gas chromatography–mass spectrometry |
| PLK1 | Polo-like kinase 1 |
| TP53 | Tumor protein p53 |
| BAX | BCL2-associated X |
| P21 | Protein 21 |
| HepG2 | Human hepatocellular carcinomas |
| Bax | BCL2-associated X |
| Bcl | B-cell lymphoma-2 |
| CNE | Human nasopharyngeal cancer cell |
| SBD | Scutellaria barbata D. Don |
| VEGFA | Vascular endothelial growth factor A |
| p-EGFR | p-Epidermal growth factor receptor |
| PDE7B | cAMP-specific 3′,5′-cyclic phosphodiesterase 7B |
| PTHrP | Parathyroid-hormone-related protein |
| HD-SB | Hedyotis diffusa–Scutellaria barbata |
| Smad | Drosophila mothers against decapentaplegic protein |
| MMP | Matrix metalloproteinase |
| EMT | Epithelial–mesenchymal transition |
| EGFR | Epidermal growth factor receptor |
| HUVEC | Human umbilical vein endothelial cells |
| ROS | Reactive oxygen species |
| LMO1 | LIM domain only 1 |
| PFS | Progression-free survival |
| OS | Overall survival |